The Evidence-Based Use of FFP and Cryoprecipitate for Abnormalities of Coagulation Tests and Clinical Coagulopathy
Open Access
- 1 January 2007
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2007 (1), 179-186
- https://doi.org/10.1182/asheducation-2007.1.179
Abstract
There continues to be a general but unfounded enthusiasm for fresh frozen plasma (FFP) or frozen plasma (FP) usage across a range of clinical specialties in hospital practice. Plasma for transfusion is most often used where there are abnormal coagulation screening tests, either therapeutically in the face of bleeding, or prophylactically in nonbleeding patients prior to invasive procedures or surgery. Little evidence exists to inform best therapeutic transfusion practice, and most studies describe plasma use in a prophylactic setting. Laboratory abnormalities of coagulation are considered by many clinicians to be a predictive risk factor for bleeding prior to invasive procedures or in other clinical situations where bleeding risk exists, and plasma for transfusion is presumed to improve the laboratory results and reduce this risk. However, most guideline indications for the prophylactic use of plasma for transfusion are not supported by evidence from good-quality randomized trials. Arguably, the strongest randomized controlled trial (RCT) evidence indicates that prophylactic plasma for transfusion is not effective across a range of different clinical settings, and this is supported by data from nonrandomized studies in patients with mild to moderate abnormalities in coagulation tests. There is a need to undertake new trials evaluating the efficacy and adverse effects of plasma, both in bleeding and non-bleeding patients, to understand whether the presumed benefits outweigh the real risks. In addition, new hemostatic tests that better define the risk of bleeding and monitor the effectiveness of the use of FFP should be validated. Last, there is an opportunity to develop effective educational strategies aimed at addressing understanding and compliance with recommendations in guidelines.Keywords
This publication has 47 references indexed in Scilit:
- International Normalized Ratio in patients not on vitamin K antagonistsJournal of Thrombosis and Haemostasis, 2007
- Should plasma be transfused prophylactically before invasive procedures?Current Opinion in Hematology, 2006
- Effect of fresh‐frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalitiesTransfusion, 2006
- Toward Rational Fresh Frozen Plasma TransfusionAmerican Journal of Clinical Pathology, 2006
- Treatment of thrombotic thrombocytopenic purpuraVox Sanguinis, 2006
- The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasmaTransfusion, 2006
- The quality of fresh‐frozen plasma produced from whole blood stored at 4°C overnightTransfusion, 2005
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation testsHepatology, 2005
- Controlled study of treatment for disseminated intravascular coagulation in the neonateThe Journal of Pediatrics, 1982
- Bleeding after liver biopsy does not correlate with indices of peripheral coagulationDigestive Diseases and Sciences, 1981